Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis and in vitro studies of radiolabeled and fluorescent aromatase inhibitors

Thesis/Dissertation ·
OSTI ID:7068386
7a-Substituted 4-androstene-3,17-diones are effective inhibitors of aromatase in vitro. One of the potent competitive inhibitors in the series, 7a-(4{prime}-iodo)phenylthio-4-androstene-3,17-dione (7a-IPTA) with an apparent K{sub i} of 12 nM, was prepared as a {sup 125}I-radiolabeled probe. Metabolism studies on human placental microsomes of {sup 125}I-7a-IPTA demonstrated that deiodination, cleavage of the 7a-thio substituent and metabolites No. 1, No. 2, and No. 3, and di-iodothiophenol are produced. MCF-7 cells metabolism of IPTA showed the metabolites No. 1 and No. 2 were the major metabolites. Comparing the retention time and by coelution, metabolite No. 1 was shown to be identical to 7a-(4{prime}iodo)phenylthio-17B-hydroxy-4-androsten-3-one. Synthetic analogs of a 7a-substituted 4-3n3-3,17-dione or 1,4-idene-3,17-diene-3,17-dione have been evaluated as inhibitors of human placental microsomal aromatase, with apparent K{sub i} ranges of 4.4-86.7 nM at apparent K{sub m} ranges of 53.3-74.8 nM, and V{sub max} ranges of 112.8-236.4 nmol/mg protein/min. Naphthylthio derivatives are about 3-4 fold more effective than dinitrophenyl derivatives. The 1,4-diene steroids have better aromatase inhibitory activity than 4-ene steroids. Particularly, IPTADD is the most potent inhibitor in the series.
Research Organization:
Ohio State Univ., Columbus, OH (USA)
OSTI ID:
7068386
Country of Publication:
United States
Language:
English